Illumina faces EU gun-jumping probe over Grail acquisition

The European Commission has opened a gun-jumping investigation into Illumina, two days after the biotechnology company completed its acquisition of Grail in the midst of the EU’s in-depth merger review.


Get unlimited access to all Global Competition Review content